Differential response to ofatumumab in anti-AChR and anti-MuSK positive myasthenia gravis patients: a single-center retrospective study
OFA demonstrates superior efficacy in MuSK-MG with distinct immunological modulation. AChR-MG requires combinatorial strategies targeting compensatory pathways.
Authors
- Miao Su (ORCID: https://orcid.org/0000-0002-8750-7204)
- Qiuming Zeng
- Fei Jiang (ORCID: https://orcid.org/0000-0002-2380-1498)
- Haobing Cai
- Xiang Wei (ORCID: https://orcid.org/0000-0001-8812-6377)
- Xiaohua Dong
- Guanzhong Shi
- Zeyi Wen
- Kailin Li
- Ting He
- Huan Yang
- Qian Zhou
Institutions
- Central South University (CN)
- Xiangya Hospital Central South University (CN)
Publication Details
- Journal
- Therapeutic Advances in Neurological Disorders
- Published
- 2026-02-17
- DOI
- https://doi.org/10.1177/17562864261421717
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00